Healixa Inc.
EMOR · OTC
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Revenue | $599 | $9 | $0 | $59 |
| % Growth | 6,688.5% | – | -100% | – |
| Cost of Goods Sold | $388 | $33 | $23 | $109 |
| Gross Profit | $211 | -$24 | -$23 | -$50 |
| % Margin | 35.2% | -275.3% | – | -83.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $6,564 | $531 | $2,596 | $3,024 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $6,564 | $531 | $2,596 | $3,024 |
| Operating Income | -$6,353 | -$555 | -$2,619 | -$3,074 |
| % Margin | -1,060.9% | -6,292.1% | – | -5,170.8% |
| Other Income/Exp. Net | -$377 | -$90 | -$224 | -$11,984 |
| Pre-Tax Income | -$6,730 | -$645 | -$2,843 | -$15,058 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$6,730 | -$645 | -$2,843 | -$15,058 |
| % Margin | -1,123.8% | -7,316.1% | – | -25,329.4% |
| EPS | -0.009 | -0.001 | -0.004 | -0.019 |
| % Growth | -987.5% | 77.1% | 81.2% | – |
| EPS Diluted | -0.009 | -0.001 | -0.004 | -0.019 |
| Weighted Avg Shares Out | 772,795 | 778,072 | 817,116 | 810,119 |
| Weighted Avg Shares Out Dil | 772,795 | 778,072 | 817,116 | 810,119 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $380 | $550 | $224 | $11 |
| Depreciation & Amortization | $33 | $33 | $23 | $86 |
| EBITDA | -$6,320 | -$522 | -$2,596 | -$14,961 |
| % Margin | -1,055.4% | -5,916.8% | – | -25,166.4% |